HEADER PROTEIN FIBRIL 14-DEC-10 2Y29 TITLE STRUCTURE OF SEGMENT KLVFFA FROM THE AMYLOID-BETA PEPTIDE (AB, TITLE 2 RESIDUES 16-21), ALTERNATE POLYMORPH III COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA A4 PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SEGMENT KLVFFA, RESIDUES 687-692; COMPND 5 SYNONYM: AMYLOID BETA PEPTIDE, ABPP, APPI, APP, ALZHEIMER DISEASE COMPND 6 AMYLOID PROTEIN, CEREBRAL VASCULAR AMYLOID PEPTIDE, CVAP, PREA4, COMPND 7 PROTEASE NEXIN-II, PN-II; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS PROTEIN FIBRIL, ALZHEIMER DISEASE EXPDTA X-RAY DIFFRACTION AUTHOR J.COLLETIER,A.LAGANOWSKY,M.R.SAWAYA,D.EISENBERG REVDAT 2 08-MAY-24 2Y29 1 REMARK REVDAT 1 26-OCT-11 2Y29 0 JRNL AUTH J.COLLETIER,A.LAGANOWSKY,M.LANDAU,M.ZHAO,A.B.SORIAGA, JRNL AUTH 2 L.GOLDSCHMIDT,D.FLOT,D.CASCIO,M.R.SAWAYA,D.EISENBERG JRNL TITL MOLECULAR BASIS FOR AMYLOID-{BETA} POLYMORPHISM. JRNL REF PROC.NATL.ACAD.SCI.USA V. 108 16938 2011 JRNL REFN ISSN 0027-8424 JRNL PMID 21949245 JRNL DOI 10.1073/PNAS.1112600108 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0081 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 3 NUMBER OF REFLECTIONS : 251 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 14 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 26 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2760 REMARK 3 BIN FREE R VALUE SET COUNT : 1 REMARK 3 BIN FREE R VALUE : 0.6830 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 52 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 2 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.13 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.45000 REMARK 3 B22 (A**2) : 11.80000 REMARK 3 B33 (A**2) : -0.34000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.141 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.061 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.080 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.543 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 53 ; 0.023 ; 0.023 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 70 ; 1.519 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 5 ; 5.136 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 2 ;14.728 ;20.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 9 ;19.219 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 8 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 38 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2Y29 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-DEC-10. REMARK 100 THE DEPOSITION ID IS D_1290046721. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.87260 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 266 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.19000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.40 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.52000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.190 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 29.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.73 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AB16-21 FORM III CRYSTALS WERE REMARK 280 OBTAINED AFTER THE SEGMENT WAS DISSOLVED IN WATER AT 5 MG/ML AND REMARK 280 MIXED WITH 0.2M AMMONIUM ACETATE, 0.1 M TRIS BUFFER PH 8.5 AND REMARK 280 30% ISOPROPANOL. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 4.79500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 21.10500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 6.03500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 21.10500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 4.79500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 6.03500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UOA RELATED DB: PDB REMARK 900 AFTER 3NS REMARK 900 RELATED ID: 1TAW RELATED DB: PDB REMARK 900 BOVINE TRYPSIN COMPLEXED TO APPI REMARK 900 RELATED ID: 2Y3J RELATED DB: PDB REMARK 900 STRUCTURE OF SEGMENT AIIGLM FROM THE AMYLOID-BETA PEPTIDE (AB, REMARK 900 RESIDUES 30-35) REMARK 900 RELATED ID: 1TKN RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF CAPPD*, AN INDEPENDENTLY FOLDEDEXTRACELLULAR REMARK 900 DOMAIN OF HUMAN AMYLOID-BETA PRECURSORPROTEIN REMARK 900 RELATED ID: 1QCM RELATED DB: PDB REMARK 900 AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES REMARK 900 RELATED ID: 1BA6 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE REMARK 900 (1-40). DOES OXIDATION AFFECT CONFORMATIONAL SWITCHING? NMR, 10 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1QYT RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF FRAGMENT (25-35) OF BETA AMYLOIDPEPTIDE IN REMARK 900 SDS MICELLAR SOLUTION REMARK 900 RELATED ID: 1BJB RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF AMYLOID BETA[E16], RESIDUES 1-28, 14 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 2Y3L RELATED DB: PDB REMARK 900 STRUCTURE OF SEGMENT MVGGVVIA FROM THE AMYLOID-BETA PEPTIDE (AB, REMARK 900 RESIDUES 35-42), ALTERNATE POLYMORPH 2 REMARK 900 RELATED ID: 2Y2A RELATED DB: PDB REMARK 900 STRUCTURE OF SEGMENT KLVFFA FROM THE AMYLOID-BETA PEPTIDE (AB, REMARK 900 RESIDUES 16-21), ALTERNATE POLYMORPH I REMARK 900 RELATED ID: 2Y3K RELATED DB: PDB REMARK 900 STRUCTURE OF SEGMENT MVGGVVIA FROM THE AMYLOID-BETA PEPTIDE (AB, REMARK 900 RESIDUES 35-42), ALTERNATE POLYMORPH 1 REMARK 900 RELATED ID: 1CA0 RELATED DB: PDB REMARK 900 BOVINE CHYMOTRYPSIN COMPLEXED TO APPI REMARK 900 RELATED ID: 1UO8 RELATED DB: PDB REMARK 900 AFTER 2NS REMARK 900 RELATED ID: 1BRC RELATED DB: PDB REMARK 900 RELATED ID: 1BA4 RELATED DB: PDB REMARK 900 THE SOLUTION STRUCTURE OF AMYLOID BETA-PEPTIDE (1-40 ) IN A WATER- REMARK 900 MICELLE ENVIRONMENT. IS THE MEMBRANE- SPANNING DOMAIN WHERE WE REMARK 900 THINK IT IS? NMR, 10 STRUCTURES REMARK 900 RELATED ID: 1AAP RELATED DB: PDB REMARK 900 RELATED ID: 2WK3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH REMARK 900 AMYLOID-BETA (1-42) REMARK 900 RELATED ID: 1QWP RELATED DB: PDB REMARK 900 NMR ANALYSIS OF 25-35 FRAGMENT OF BETA AMYLOID PEPTIDE REMARK 900 RELATED ID: 1X11 RELATED DB: PDB REMARK 900 X11 PTB DOMAIN REMARK 900 RELATED ID: 1ZE9 RELATED DB: PDB REMARK 900 ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE REMARK 900 COMPLEXED WITH A ZINC (II) CATION REMARK 900 RELATED ID: 1QXC RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE FRAGMENT 25-35 OF BETA AMYLOID PEPTIDEIN 20/80 REMARK 900 V:V HEXAFLUOROISOPROPANOL/WATER MIXTURE REMARK 900 RELATED ID: 1IYT RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE REMARK 900 (1-42) REMARK 900 RELATED ID: 1ZE7 RELATED DB: PDB REMARK 900 ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE IN REMARK 900 WATER SOLUTION AT PH 6.5 REMARK 900 RELATED ID: 2BEG RELATED DB: PDB REMARK 900 3D STRUCTURE OF ALZHEIMER'S ABETA(1-42) FIBRILS REMARK 900 RELATED ID: 1UOI RELATED DB: PDB REMARK 900 AFTER 4NS REMARK 900 RELATED ID: 1AMB RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE (RESIDUES 1 - 28) (NMR, REMARK 900 MINIMIZED AVERAGE STRUCTURE) REMARK 900 RELATED ID: 1RW6 RELATED DB: PDB REMARK 900 HUMAN APP CORE DOMAIN REMARK 900 RELATED ID: 1UO7 RELATED DB: PDB REMARK 900 MOLECULAR DYNAMICS SIMULATION OF AMYLOID BETA 1-42 ( PDB: 1IYT) IN REMARK 900 WATER REMARK 900 RELATED ID: 1OWT RELATED DB: PDB REMARK 900 STRUCTURE OF THE ALZHEIMER'S DISEASE AMYLOID PRECURSORPROTEIN REMARK 900 COPPER BINDING DOMAIN REMARK 900 RELATED ID: 1AML RELATED DB: PDB REMARK 900 THE ALZHEIMER'S DISEASE AMYLOID A4 PEPTIDE (RESIDUES 1 -40) REMARK 900 RELATED ID: 1AMC RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE (RESIDUES 1 - 28) (NMR, 5 REMARK 900 STRUCTURES) REMARK 900 RELATED ID: 2BP4 RELATED DB: PDB REMARK 900 ZINC-BINDING DOMAIN OF ALZHEIMER'S DISEASE AMYLOID BETA-PEPTIDE IN REMARK 900 TFE-WATER (80-20) SOLUTION REMARK 900 RELATED ID: 1ZJD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATIONFACTOR XI REMARK 900 IN COMPLEX WITH KUNITZ PROTEASE INHIBITOR DOMAINOF PROTEASE NEXIN II REMARK 900 RELATED ID: 2BOM RELATED DB: PDB REMARK 900 MODEL OF ALZHEIMER'S DISEASE AMYLOID-SS PEPTIDE BASED ON A RNA REMARK 900 BINDING PROTEIN REMARK 900 RELATED ID: 1BJC RELATED DB: PDB REMARK 900 SOLUTION NMR STRUCTURE OF AMYLOID BETA[F16], RESIDUES 1-28, 15 REMARK 900 STRUCTURES REMARK 900 RELATED ID: 1MWP RELATED DB: PDB REMARK 900 N-TERMINAL DOMAIN OF THE AMYLOID PRECURSOR PROTEIN REMARK 900 RELATED ID: 1HZ3 RELATED DB: PDB REMARK 900 ALZHEIMER'S DISEASE AMYLOID-BETA PEPTIDE (RESIDUES 10- 35) REMARK 999 REMARK 999 SEQUENCE REMARK 999 IN VIVO AMYLOID BETA PEPTIDE (AB) IS A PROTEOLYTIC PRODUCT OF REMARK 999 THE AMYLOID PRECURSOR PROTEIN (APP). AB SEGMENT 16-KLVFFA-21 REMARK 999 CORRESPONDS TO RESIDUES 687-692 OF APP DBREF 2Y29 A 2 7 UNP P05067 A4_HUMAN 687 692 SEQRES 1 A 6 LYS LEU VAL PHE PHE ALA FORMUL 2 HOH *2(H2 O) CRYST1 9.590 12.070 42.210 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.104275 0.000000 0.000000 0.00000 SCALE2 0.000000 0.082850 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023691 0.00000 ATOM 1 N LYS A 2 -3.367 5.703 7.940 1.00 24.11 N ATOM 2 CA LYS A 2 -3.973 6.815 7.193 1.00 25.75 C ATOM 3 C LYS A 2 -4.182 6.420 5.718 1.00 22.45 C ATOM 4 O LYS A 2 -5.254 5.972 5.404 1.00 22.63 O ATOM 5 CB LYS A 2 -3.204 8.133 7.368 1.00 36.28 C ATOM 6 CG LYS A 2 -3.553 8.966 8.663 1.00 37.36 C ATOM 7 CD LYS A 2 -4.568 10.129 8.386 1.00 43.82 C ATOM 8 CE LYS A 2 -4.592 11.222 9.509 1.00 38.18 C ATOM 9 NZ LYS A 2 -5.860 12.074 9.514 1.00 37.31 N ATOM 10 N LEU A 3 -3.178 6.516 4.843 1.00 20.46 N ATOM 11 CA LEU A 3 -3.378 6.265 3.417 1.00 16.76 C ATOM 12 C LEU A 3 -2.869 4.947 2.927 1.00 15.82 C ATOM 13 O LEU A 3 -1.662 4.690 3.015 1.00 14.04 O ATOM 14 CB LEU A 3 -2.742 7.362 2.566 1.00 18.25 C ATOM 15 CG LEU A 3 -2.870 7.162 1.045 1.00 20.82 C ATOM 16 CD1 LEU A 3 -4.316 7.370 0.513 1.00 18.21 C ATOM 17 CD2 LEU A 3 -1.880 8.040 0.272 1.00 23.81 C ATOM 18 N VAL A 4 -3.775 4.132 2.356 1.00 14.07 N ATOM 19 CA VAL A 4 -3.374 2.906 1.669 1.00 14.54 C ATOM 20 C VAL A 4 -3.942 2.715 0.301 1.00 16.12 C ATOM 21 O VAL A 4 -5.144 2.489 0.125 1.00 18.28 O ATOM 22 CB VAL A 4 -3.682 1.660 2.471 1.00 14.30 C ATOM 23 CG1 VAL A 4 -3.181 0.420 1.697 1.00 14.29 C ATOM 24 CG2 VAL A 4 -3.007 1.755 3.808 1.00 13.11 C ATOM 25 N PHE A 5 -3.053 2.791 -0.676 1.00 19.17 N ATOM 26 CA PHE A 5 -3.405 2.635 -2.083 1.00 18.86 C ATOM 27 C PHE A 5 -2.753 1.390 -2.696 1.00 18.52 C ATOM 28 O PHE A 5 -1.542 1.185 -2.546 1.00 19.22 O ATOM 29 CB PHE A 5 -2.989 3.886 -2.863 1.00 19.73 C ATOM 30 CG PHE A 5 -3.228 3.777 -4.344 1.00 19.23 C ATOM 31 CD1 PHE A 5 -2.407 2.992 -5.140 1.00 19.50 C ATOM 32 CD2 PHE A 5 -4.274 4.472 -4.940 1.00 19.79 C ATOM 33 CE1 PHE A 5 -2.646 2.881 -6.512 1.00 20.32 C ATOM 34 CE2 PHE A 5 -4.511 4.367 -6.279 1.00 19.74 C ATOM 35 CZ PHE A 5 -3.696 3.559 -7.072 1.00 19.06 C ATOM 36 N PHE A 6 -3.559 0.594 -3.396 1.00 18.19 N ATOM 37 CA PHE A 6 -3.115 -0.607 -4.121 1.00 21.35 C ATOM 38 C PHE A 6 -3.888 -0.800 -5.415 1.00 24.27 C ATOM 39 O PHE A 6 -5.062 -1.252 -5.404 1.00 21.75 O ATOM 40 CB PHE A 6 -3.208 -1.925 -3.274 1.00 21.59 C ATOM 41 CG PHE A 6 -2.330 -3.029 -3.805 1.00 23.29 C ATOM 42 CD1 PHE A 6 -0.920 -2.975 -3.642 1.00 24.72 C ATOM 43 CD2 PHE A 6 -2.870 -4.096 -4.537 1.00 22.64 C ATOM 44 CE1 PHE A 6 -0.091 -3.994 -4.191 1.00 24.66 C ATOM 45 CE2 PHE A 6 -2.037 -5.101 -5.091 1.00 19.71 C ATOM 46 CZ PHE A 6 -0.672 -5.068 -4.920 1.00 19.51 C ATOM 47 N ALA A 7 -3.223 -0.505 -6.532 1.00 24.61 N ATOM 48 CA ALA A 7 -3.827 -0.715 -7.821 1.00 26.63 C ATOM 49 C ALA A 7 -3.187 -1.922 -8.487 1.00 31.16 C ATOM 50 O ALA A 7 -1.980 -1.962 -8.645 1.00 29.56 O ATOM 51 CB ALA A 7 -3.694 0.510 -8.669 1.00 29.69 C ATOM 52 OXT ALA A 7 -3.840 -2.909 -8.854 1.00 38.24 O TER 53 ALA A 7 HETATM 54 O HOH A2001 -5.967 -2.380 -10.310 1.00 17.97 O HETATM 55 O HOH A2002 -6.843 -4.832 -7.024 1.00 29.82 O MASTER 341 0 0 0 0 0 0 6 54 1 0 1 END